Skip to Content
UW Health SMPH
American Family Children's Hospital
SHARE TEXT
Igor I. Slukvin, PhD, MD close
Igor I. Slukvin, PhD, MD


For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

Igor I. Slukvin, PhD, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Igor I. Slukvin, PhD, MD, earned his medical degree from Kiev Medical University in Ukraine and completed his residency at UW Hospital and Clinics.

Specialties

Pathology

UW Health Clinics

UW Hospital and Clinics
(608) 263-8437 | (800) 323-8942 | Map

Hospital Affiliation(s)

University of Wisconsin Hospital and Clinics (primary)
Veterans Hospital - Wm. S. Middleton Memorial (secondary)

UW School of Medicine and Public Health

Department of Pathology and Laboratory Medicine

Professional Certifications and Education

Board Certification Anatomic Pathology & Clinical Pathology
Residency University of Wisconsin Hospital and Clinics, Madison, WI
Medical School Kiev Medical University, Ukraine, 1984

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Uenishi G Theisen D Lee JH Kumar A Raymond M Vodyanik M Swanson S Stewart R Thomson J Slukvin I . Tenascin C promotes hematoendothelial development and T lymphoid commitment from human pluripotent stem cells in chemically defined conditions. Stem Cell Reports. 2014 Dec 9;3(6):1073-84
[PubMed ID: 25448067]
Elcheva I Brok-Volchanskaya V Kumar A Liu P Lee JH Tong L Vodyanik M Swanson S Stewart R Kyba M Yakubov E Cooke J Thomson JA Slukvin I . Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators. Nat Commun. 2014 Jul 14;5:4372
[PubMed ID: 25019369]
Slukvin II . Deciphering the hierarchy of angiohematopoietic progenitors from human pluripotent stem cells. Cell Cycle. 2013 Mar 1;12(5):720-7
[PubMed ID: 23388453]
Hu K Slukvin I . Generation of transgene-free iPSC lines from human normal and neoplastic blood cells using episomal vectors. Methods Mol Biol. 2013;997:163-76
[PubMed ID: 23546755]
Choi KD Vodyanik MA Togarrati PP Suknuntha K Kumar A Samarjeet F Probasco MD Tian S Stewart R Thomson JA Slukvin II . Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures. Cell Rep. 2012 Sep 27;2(3):553-67
[PubMed ID: 22981233]
Slukvin II . Epicardial origin of cardiac CFU-Fs. Cell Stem Cell. 2011 Dec 2;9(6):492-3
[PubMed ID: 22136919]
Dias J Gumenyuk M Kang H Vodyanik M Yu J Thomson JA Slukvin II . Generation of red blood cells from human induced pluripotent stem cells. Stem Cells Dev. 2011 Sep;20(9):1639-47
[PubMed ID: 21434814]
Slukvin II Vodyanik M . Endothelial origin of mesenchymal stem cells. Cell Cycle. 2011 May 1;10(9):1370-3
[PubMed ID: 21444996]
Hu K Yu J Suknuntha K Tian S Montgomery K Choi KD Stewart R Thomson JA Slukvin II . Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood. 2011 Apr 7;117(14):e109-19
[PubMed ID: 21296996]
Salvagiotto G Burton S Daigh CA Rajesh D Slukvin II Seay NJ . A defined, feeder-free, serum-free system to generate in vitro hematopoietic progenitors and differentiated blood cells from hESCs and hiPSCs. PLoS One. 2011 Mar 18;6(3):e17829
[PubMed ID: 21445267]
Choi KD Vodyanik M Slukvin II . Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells. Nat Protoc. 2011 Mar;6(3):296-313
[PubMed ID: 21372811]
Vodyanik MA Yu J Zhang X Tian S Stewart R Thomson JA Slukvin II . A mesoderm-derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell. 2010 Dec 3;7(6):718-29
[PubMed ID: 21112566]
Choi KD Vodyanik MA Slukvin II . Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors. J Clin Invest. 2009 Sep;119(9):2818-29
[PubMed ID: 19726877]
Yu J Hu K Smuga-Otto K Tian S Stewart R Slukvin II Thomson JA . Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009 May 8;324(5928):797-801
[PubMed ID: 19325077]
Slukvin II . Renin-angiotensin system and hemangioblast development from human embryonic stem cells. Expert Rev Hematol. 2009 Apr;2(2):137-43
[PubMed ID: 21083448]
Choi KD Yu J Smuga-Otto K Salvagiotto G Rehrauer W Vodyanik M Thomson J Slukvin I . Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells. 2009 Mar;27(3):559-67
[PubMed ID: 19259936]
Metallo CM Vodyanik MA de Pablo JJ Slukvin II Palecek SP . The response of human embryonic stem cell-derived endothelial cells to shear stress. Biotechnol Bioeng. 2008 Jul 1;100(4):830-7
[PubMed ID: 18306423]
Yu J Vodyanik MA Smuga-Otto K Antosiewicz-Bourget J Frane JL Tian S Nie J Jonsdottir GA Ruotti V Stewart R Slukvin II Thomson JA . Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007 Dec 21;318(5858):1917-20
[PubMed ID: 18029452]
Vodyanik MA Slukvin II . Hematoendothelial differentiation of human embryonic stem cells. Curr Protoc Cell Biol. 2007 Sep;Chapter 23:Unit 23.6
[PubMed ID: 18228507]
Rajesh D Chinnasamy N Mitalipov SM Wolf DP Slukvin I Thomson JA Shaaban AF . Differential requirements for hematopoietic commitment between human and rhesus embryonic stem cells. Stem Cells. 2007 Feb;25(2):490-9
[PubMed ID: 17284653]